Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 4—April 2012

Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB

Jurriaan E.M. de SteenwinkelComments to Author , Marian T. ten Kate, Gerjo J. de Knegt, Kristin Kremer, Rob E. Aarnoutse, Martin J. Boeree, Henri A. Verbrugh, Dick van Soolingen, and Irma A.J.M. Bakker-Woudenberg
Author affiliations: Erasmus University Medical Center, Rotterdam, the Netherlands (J.E.M. de Steenwinkel, M.T. ten Kate, G.J. de Knegt, H.A. Verbrugh, I.A.J.M. Bakker-Woudenberg); National Institute of Public Health and the Environment Center for Infectious Disease Control (RIVM),; Bilthoven, the Netherlands (K. Kremer, D. van Soolingen); World Health Organization Regional Office for Europe, Copenhagen, Denmark (K. Kremer); Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands (R.E. Aarnoutse, M.J. Boeree, D. van Soolingen)

Main Article

Table 2

Concentration- and time-dependent bactericidal effect of rifampin toward Mycobacterium tuberculosis genotypes in low- and high-density cultures*

Day Lowest RIF concentration resulting in killing of M. tuberculosis, mg/L
Beijing-1585 genotype
EAI-1627 genotype
>99% killing
100% killing
>99% killing
100% killing
Low† High‡ Low† High‡ Low§ High¶ Low§ High¶
1 8 ND 256 ND 8 ND 32 ND
3 1 0.008 64 1024 0.125 0.03 8 32
6 0.001 0.008 2 64 0.001 0.06 1 2

*Cultures were exposed to RIF at 2-fold increasing concentrations for 6 days at 37°C; at indicated time-points, subcultures were performed on solid media for counting. Low, low-density culture; high, high-density culture; ND, not determined.
†Density of 5.1 × 105 CFU/mL.
‡Density of 4.4 × 106 CFU/mL.
§Density of 6.8 × 105 CFU/mL.
¶Density of 3.0 × 106 CFU/mL.

Main Article

Page created: March 15, 2012
Page updated: March 15, 2012
Page reviewed: March 15, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.